Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche’s Pharma Day - Monday, 16th September 2019 Montag, 05. August 2019 - 10:02

?v=05292019124700 

7fa5b9fb-fe8a-4170-b0cd-68f15c0c2107

Invitation to Roche's Pharma Day - Monday, 16th  September 2019

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 16th  September 2019, starting at 9:30am local time.

Presentations will be held in the morning, followed by lunch and breakout sessions in the afternoon. The event will finish at 2:45pm local time with a buffet reception held afterwards. 

The Roche Pharma Day will address the following topics:

- Pharma strategy, Portfolio planning, Productivity & New technologies
- Market opportunities, Pricing & Access

- Late stage pipeline update: Oncology, Neuroscience, Immunology, Infectious diseases & Ophthalmology
- Digitalisation & Personalized healthcare

Speakers include Bill Anderson, Teresa Graham, Sandra Horning, Paulo Fontoura and key franchise heads. You will have the opportunity to meet senior management during the event.

Presentations will also be publicly available via a live video webcast on 
> http://ir.roche.com

Meeting information: 
Date/Time (BST):
Monday, 16th September 2019
09:00am Registration
09:30am Event starts
2:45pm Event ends
followed by a buffet reception

Venue
Hilton London Tower Bridge
5 More London Place
Tooley Street, London
SE1 2BY
map


To register for the event please follow this > link

Alternatively, you may dial in to the conference.
T
o expedite the registration process on the day of the event, please pre-register for the conference call, click > here, or dial in using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start:

+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 203 059 5862 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

A replay of the webcast will be available on demand at 
> http://ir.roche.com


Best regards,

Karl Mahler 
Head of Investor Relations



Bruno Eschli
Investor Relations Officer

Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: 
jon_kaspar.bayard@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: 
gerard.tobin@roche.com

 

 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com

Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: 
tuomi.lisa@gene.com

 

 

All rights reserved ©2019 F. Hoffmann-La Roche Ltd.
Investor Relations, Grenzacherstrasse 124, CH-4070 Basel, Switzerland